Synthego stock

Synthego Stock

HealthTech

Looking to sell Synthego stock or options?

Founded: 2012Funding to Date: $415Mhttps://www.synthego.com

Synthego offers a precision genome engineering platform aimed at streamlining and enhancing the drug discovery research process. Utilizing informatics and machine learning, the platform delivers precision and automation in genome engineering. This enables genetic engineers and medical professionals to perform research quickly and cost-effectively while ensuring consistent outcomes.

Investors Include:

Perceptive Advisors, Declaration Partners, Moore Strategic Ventures, Menlo Ventures, ZhenFund, AAF Management, Wellington Management, 8VC, Elements Capital Partners, GigaFund, AME Cloud Ventures, Tony Huang, SciFi VC, Moshen Chan, Chimera Capital, Intel Capital, Revelation Partners, Open Field Capital, Level One Fund, OS Fund, RA Capital Management, Founders Fund, Logos Capital, Alexandria Real Estate Equities, WI Harper Group.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more